Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gilmore

Showing results (321-330 of 336) with videos related to

Pageof 34
Sort By:
Frontiers in Molecular Neuroscience|August 24, 2023
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's diseaseKaitlin Flannagan, Julia A Stopperan, Brittany M Hauger, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Proteomic and metabolic profiling reveals <i>APOE4</i>-dependent shifts in whole brain, neuronal, and astrocytic mitochondrial function and glycolysisColton R Lysaker, Chelsea N Johnson, Vivien Csikos, et al.
Science Immunology|February 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availabilityValeria Fumagalli, Valentina Venzin, Pietro Di Lucia, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
The Lancet. Neurology|December 25, 2019
Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trialNagy Mekhail, Robert M Levy, Timothy R Deer, et al.
The Journal of Physiology|May 11, 2025
A polygenetic rat model of divergent aerobic capacity reveals a liver-brain interaction impacting Alzheimer's disease-like phenotypesColton R Lysaker, Benjamin A Kugler, Vivien Csikos, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
Journal of Medicinal Chemistry|July 13, 2001
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domainJ R Proudfoot, R Betageri, M Cardozo, et al.
Pain Reports|October 15, 2024
Validation of a holistic composite outcome measure for the evaluation of chronic pain interventionsRod S Taylor, Quinton Neville, Christopher M Mullin, et al.
Interventional Pain Medicine|June 15, 2026
Observations from the RESET clinical trial: A post-hoc per protocol analysis of clinical outcomes with percutaneous 60-day medial branch PNS in chronic low back painSean Li, Zachary L McCormick, Denise D Lester, et al.
Pageof 34

Showing results (321-330 of 336) with videos related to

Sort By:
Pageof 34
Frontiers in Molecular Neuroscience|August 24, 2023
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's diseaseKaitlin Flannagan, Julia A Stopperan, Brittany M Hauger, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Proteomic and metabolic profiling reveals <i>APOE4</i>-dependent shifts in whole brain, neuronal, and astrocytic mitochondrial function and glycolysisColton R Lysaker, Chelsea N Johnson, Vivien Csikos, et al.
Science Immunology|February 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availabilityValeria Fumagalli, Valentina Venzin, Pietro Di Lucia, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Ricardo Chatelain, Kevin B Clairmont, et al.
The Lancet. Neurology|December 25, 2019
Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trialNagy Mekhail, Robert M Levy, Timothy R Deer, et al.
The Journal of Physiology|May 11, 2025
A polygenetic rat model of divergent aerobic capacity reveals a liver-brain interaction impacting Alzheimer's disease-like phenotypesColton R Lysaker, Benjamin A Kugler, Vivien Csikos, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
Journal of Medicinal Chemistry|July 13, 2001
Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domainJ R Proudfoot, R Betageri, M Cardozo, et al.
Pain Reports|October 15, 2024
Validation of a holistic composite outcome measure for the evaluation of chronic pain interventionsRod S Taylor, Quinton Neville, Christopher M Mullin, et al.
Interventional Pain Medicine|June 15, 2026
Observations from the RESET clinical trial: A post-hoc per protocol analysis of clinical outcomes with percutaneous 60-day medial branch PNS in chronic low back painSean Li, Zachary L McCormick, Denise D Lester, et al.
Pageof 34